Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inositol for Anxiety in Pediatric Bipolar Disorder
NCT02811133Phase 2Withdrawn
- Start
- Aug 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bCalm in anxiety disorder, bipolar disorder (BD). Planned start Aug 2023; status: withdrawn.
02
Drugs
bCalm
03
Conditions
anxiety disorderbipolar disorder (BD)
Beyond the preview
Go deeper on NCT02811133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02811133.